By Press release submission |
Jan 31, 2023
2015—the year that the Centers for Medicare & Medicaid Services (CMS) added antipsychotic medication use quality measures (QMs) to the Five-Star Quality Rating System—marked the beginning of some difficult trends in the potentially inappropriate diagnosis of schizophrenia for long-stay nursing home residents, according to the November 2022 report Long-Term Trends of Psychotropic Drug Use in Nursing Homes from the Office of Inspector General (OIG).